Chester County News and Community Website
WILMINGTON, DE — New data from the PURSUIT Phase IIb trial reveal AstraZeneca‘s investigational oral PCSK9 inhibitor, AZD0780, delivers significant reductions in LDL cholesterol (LDL-C) when combined with standard-of-care statin …
AstraZeneca’s AZD0780 Shows Promising Results in Cholesterol-Lowering Clinical Trial Read More
SPRING HOUSE, PA — Johnson & Johnson has announced promising results from its Phase 3b APEX trial for TREMFYA® (guselkumab), revealing its effectiveness in treating active psoriatic arthritis (PsA). The …
Johnson & Johnson’s TREMFYA Demonstrates Significant Benefits in Psoriatic Arthritis Study Read More
DOYLESTOWN, PA — Aprea Therapeutics, Inc. (Nasdaq: APRE) announced a key milestone in its ACESOT-1051 clinical trial, as the first patient with HPV-positive (HPV+) head and neck squamous cell carcinoma (HNSCC) …
Aprea Therapeutics Advances ACESOT-1051 Clinical Trial with Key Patient Dosing Read More SPRING HOUSE, PA — Johnson & Johnson presented new data on its investigational treatment, nipocalimab, at the 2025 American Academy of Neurology (AAN) Annual Meeting, providing insight into its potential to …
Johnson & Johnson Showcases Promising Data on Nipocalimab for gMG at AAN Annual Meeting Read More
WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has shared promising preliminary results from its Ringer™ PBC IDE study, featured in a presentation at the CTO Plus Conference in New York. The …
Teleflex Reports Promising Preliminary Results for Ringer PBC Study Read More
RADNOR, PA — Mineralys Therapeutics, Inc. (NASDAQ: MLYS) has announced an upcoming conference call and webinar to highlight the latest findings from its pivotal Advance-HTN and Launch-HTN clinical trials. The event …
Mineralys Therapeutics to Host Webinar on Lorundsrostat and Hypertension Treatment Progress Read More
MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS), a clinical-stage biopharmaceutical company, is set to showcase significant advancements in its treatments for Alzheimer’s disease (AD) and Parkinson’s disease (PD) at the …
Annovis Bio to Present Promising Data on Buntanetap at AD/PD™ 2025 Read More
NEWTOWN, PA — Traws Pharma, Inc. (NASDAQ: TRAW) has unveiled promising preclinical and Phase 1 data for ratutrelvir, its investigational oral treatment for COVID-19. Presented at the International Conference for …
Traws Pharma Announces Promising Data for Ratutrelvir as a COVID-19 Treatment Read More WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has unveiled groundbreaking results from the CLEAR study, the first head-to-head randomized controlled trial comparing the UroLift™ System with Rezūm™ Water Vapor Therapy (WVTT) …
Study Highlights UroLift™ System’s Advantages Over Rezūm™ in Treating BPH Read More DOYLESTOWN, PA — Aprea Therapeutics, Inc. (Nasdaq: APRE), a clinical-stage biopharmaceutical company, shared its financial results for 2024 and provided a progress update on its lead programs aimed at advancing cancer …
Aprea Therapeutics Reports 2024 Financial Results and Updates on Clinical Innovations Read More